• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

左心室功能障碍对冠状动脉搭桥术中细胞因子、血流动力学及预后的影响。

Impact of left ventricular dysfunction on cytokines, hemodynamics, and outcome in bypass grafting.

作者信息

Deng M C, Dasch B, Erren M, Möllhoff T, Scheld H H

机构信息

Department of Thoracic and Cardiovascular Surgery, Muenster University Hospital, Germany.

出版信息

Ann Thorac Surg. 1996 Jul;62(1):184-90. doi: 10.1016/0003-4975(96)00230-5.

DOI:10.1016/0003-4975(96)00230-5
PMID:8678641
Abstract

BACKGROUND

Although patients with reduced left ventricular ejection fraction undergoing cardiac operation experience a higher rate of perioperative complications, the contribution of proinflammatory cytokines released during extracorporeal circulation is not well defined.

METHODS

We compared arterial and mixed venous levels of interleukin-6, tumor necrosis factor-alpha, soluble interleukin-2 receptor, and interleukin-2 at 10 points in time (24 hours before until 48 hours after extracorporeal circulation) in 21 patients with an ejection fraction of less than 0.45 (study group) to 15 patients with an ejection fraction of more than 0.55 (control group) undergoing elective coronary artery bypass grafting. The study and control group differed with regard to left ventricular ejection fraction (0.37 +/- 0.05 versus 0.66 +/- 0.11, p < 0.05) and reperfusion time (35 +/- 42 minutes versus 18 +/- 4 minutes, p = 0.07), but not age, sex, vessel involvement, number of grafts performed, cross-clamp time, extracorporeal circulation time, core temperature, and duration of ventilation.

RESULTS

Six patients in the study group required mechanical support and 1 died. There were no complications in the control group. In the study group, there were higher preoperative interleukin-2 and tumor necrosis factor-alpha levels and a higher maximum cytokine response to extracorporeal circulation for interleukin-2, soluble interleukin-2 receptor, interleukin-6, and tumor necrosis factor-alpha (all p < 0.05). Interleukin-6 correlated with duration of extracorporeal circulation, dose of norepinephrine and epinephrine support, pulmonary capillary wedge pressure, mean pulmonary arterial pressure, right atrial pressure, heart rate, cardiac index, and inversely with systemic vascular resistance. Interleukin-6 was highest in patients with complications. Arterial and venous cytokine levels correlated closely.

CONCLUSIONS

Preoperative left ventricular dysfunction is associated with a higher degree of proinflammatory cytokine release during elective coronary artery bypass grafting. This response is associated with impaired hemodynamics and a higher incidence of perioperative complications.

摘要

背景

尽管左心室射血分数降低的患者在接受心脏手术时围手术期并发症发生率较高,但体外循环期间释放的促炎细胞因子的作用尚不明确。

方法

我们比较了21例射血分数小于0.45的患者(研究组)和15例射血分数大于0.55的患者(对照组)在10个时间点(体外循环前24小时至体外循环后48小时)的动脉血和混合静脉血中白细胞介素-6、肿瘤坏死因子-α、可溶性白细胞介素-2受体和白细胞介素-2的水平。研究组和对照组在左心室射血分数(0.37±0.05对0.66±0.11,p<0.05)和再灌注时间(35±42分钟对18±4分钟,p = 0.07)方面存在差异,但在年龄、性别、血管受累情况、进行的移植血管数量、主动脉阻断时间、体外循环时间、核心温度和通气时间方面无差异。

结果

研究组有6例患者需要机械支持,1例死亡。对照组无并发症。在研究组中,术前白细胞介素-2和肿瘤坏死因子-α水平较高,白细胞介素-2、可溶性白细胞介素-2受体、白细胞介素-6和肿瘤坏死因子-α对体外循环的最大细胞因子反应较高(均p<0.05)。白细胞介素-6与体外循环时间、去甲肾上腺素和肾上腺素支持剂量、肺毛细血管楔压、平均肺动脉压、右心房压、心率、心脏指数呈正相关,与体循环血管阻力呈负相关。白细胞介素-6在有并发症的患者中最高。动脉血和静脉血中的细胞因子水平密切相关。

结论

术前左心室功能障碍与择期冠状动脉搭桥手术期间促炎细胞因子释放程度较高有关。这种反应与血流动力学受损和围手术期并发症发生率较高有关。

相似文献

1
Impact of left ventricular dysfunction on cytokines, hemodynamics, and outcome in bypass grafting.左心室功能障碍对冠状动脉搭桥术中细胞因子、血流动力学及预后的影响。
Ann Thorac Surg. 1996 Jul;62(1):184-90. doi: 10.1016/0003-4975(96)00230-5.
2
Arterial and venous cytokine response to cardiopulmonary bypass for low risk CABG and relation to hemodynamics.低风险冠状动脉旁路移植术体外循环时动静脉细胞因子反应及其与血流动力学的关系
Eur J Cardiothorac Surg. 1995;9(1):22-9. doi: 10.1016/s1010-7940(05)80044-2.
3
[Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].[β受体阻滞剂长期口服治疗对体外循环后冠心病患者使用肾上腺素进行正性肌力治疗是否有影响?]
Herz. 1995 Dec;20(6):399-411.
4
Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization.
J Thorac Cardiovasc Surg. 1994 Oct;108(4):626-35.
5
Myocardial revascularization with miniaturized extracorporeal circulation versus off pump: Evaluation of systemic and myocardial inflammatory response in a prospective randomized study.小型体外循环与非体外循环心肌血运重建:一项前瞻性随机研究中全身和心肌炎症反应的评估
J Thorac Cardiovasc Surg. 2009 May;137(5):1206-12. doi: 10.1016/j.jtcvs.2008.09.074. Epub 2009 Feb 23.
6
Sodium nitroprusside in patients with compromised left ventricular function undergoing coronary bypass: reduction of cardiac proinflammatory substances.
J Thorac Cardiovasc Surg. 2000 Mar;119(3):566-74. doi: 10.1016/s0022-5223(00)70138-3.
7
Haemodynamic, neuroendocrine and metabolic correlates of circulating cytokine concentrations in congestive heart failure.充血性心力衰竭中循环细胞因子浓度的血流动力学、神经内分泌和代谢相关性
Eur Heart J. 1997 Oct;18(10):1620-5. doi: 10.1093/oxfordjournals.eurheartj.a015142.
8
Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass.在接受体外循环的患者中,心肌是促炎细胞因子的主要来源。
J Thorac Cardiovasc Surg. 1996 Sep;112(3):806-11. doi: 10.1016/S0022-5223(96)70068-5.
9
Effectiveness of prophylactic levosimendan in patients with impaired left ventricular function undergoing coronary artery bypass grafting: a randomized pilot study.预防性左西孟旦对接受冠状动脉旁路移植术的左心室功能受损患者的疗效:一项随机试点研究。
Interact Cardiovasc Thorac Surg. 2016 Nov;23(5):740-747. doi: 10.1093/icvts/ivw213. Epub 2016 Jul 4.
10
Human cytokine responses to cardiac transplantation and coronary artery bypass grafting.人类细胞因子对心脏移植和冠状动脉旁路移植术的反应。
J Thorac Cardiovasc Surg. 1996 Feb;111(2):469-77. doi: 10.1016/s0022-5223(96)70458-0.

引用本文的文献

1
REmoval of cytokines during CArdiac surgery (RECCAS): a randomised controlled trial.心脏手术期间细胞因子清除(RECCAS):一项随机对照试验。
Crit Care. 2024 Dec 12;28(1):406. doi: 10.1186/s13054-024-05175-9.
2
Preoperative statin therapy for adults undergoing cardiac surgery.心脏手术成人患者的术前他汀治疗。
Cochrane Database Syst Rev. 2024 Jul 22;7(7):CD008493. doi: 10.1002/14651858.CD008493.pub5.
3
Strategies to attenuate maladaptive inflammatory response associated with cardiopulmonary bypass.减轻与体外循环相关的适应性炎症反应的策略。
Front Surg. 2024 Jul 3;11:1224068. doi: 10.3389/fsurg.2024.1224068. eCollection 2024.
4
Efficacy of preoperative single-dose dexamethasone in preventing postoperative pulmonary complications following minimally invasive esophagectomy: a retrospective propensity score-matched study.术前单剂量地塞米松预防微创食管癌切除术后肺部并发症的疗效:一项回顾性倾向评分匹配研究。
Perioper Med (Lond). 2024 May 28;13(1):46. doi: 10.1186/s13741-024-00407-6.
5
An exercise immune fitness test to unravel mechanisms of Post-Acute Sequelae of COVID-19.一项用于揭示新冠病毒感染后急性后遗症机制的运动免疫适应性测试。
Expert Rev Clin Immunol. 2023 Jul-Dec;19(7):693-697. doi: 10.1080/1744666X.2023.2214364. Epub 2023 May 17.
6
Comparing NGS and NanoString platforms in peripheral blood mononuclear cell transcriptome profiling for advanced heart failure biomarker development.在外周血单核细胞转录组分析中比较二代测序(NGS)和纳米孔单分子测序(NanoString)平台以开发晚期心力衰竭生物标志物
J Biol Methods. 2020 Jan 3;7(1):e123. doi: 10.14440/jbm.2020.300. eCollection 2020.
7
A peripheral blood transcriptome biomarker test to diagnose functional recovery potential in advanced heart failure.一种用于诊断晚期心力衰竭功能恢复潜力的外周血转录组生物标志物检测。
Biomark Med. 2018 Jun;12(6):619-635. doi: 10.2217/bmm-2018-0097. Epub 2018 May 8.
8
Preoperative High Dose of Methylprednisolone Improves Early Postoperative Pulmonary Function, in Super-Obese Patients Undergoing Open Surgery; a Prospective, Comparative Study.术前大剂量甲基强的松龙可改善接受开放手术的超级肥胖患者术后早期肺功能:一项前瞻性比较研究。
J Gastrointest Surg. 2016 Dec;20(12):1959-1965. doi: 10.1007/s11605-016-3281-1. Epub 2016 Oct 11.
9
RECCAS - REmoval of Cytokines during CArdiac Surgery: study protocol for a randomised controlled trial.心脏手术中细胞因子清除(RECCAS):一项随机对照试验的研究方案
Trials. 2016 Mar 12;17(1):137. doi: 10.1186/s13063-016-1265-9.
10
Casz1 is required for cardiomyocyte G1-to-S phase progression during mammalian cardiac development.在哺乳动物心脏发育过程中,Casz1是心肌细胞从G1期进入S期所必需的。
Development. 2015 Jun 1;142(11):2037-47. doi: 10.1242/dev.119107. Epub 2015 May 7.